Author:
Bruinstroop Eveline,Zhou Jin,Tripathi Madhulika,Yau Winifred W.,Boelen Anita,Singh Brijesh Kumar,Yen Paul M.
Funder
Government of Singapore Ministry of Health
Subject
Cell Biology,Molecular Biology
Reference21 articles.
1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016
2. Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD;Bruinstroop;The Journal of Clinical Endocrinology and Metabolism,2018
3. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial;Harrison;Lancet,2019
4. Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists;Sinha;Thyroid,2019
5. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist;Cable;Hepatology,2009